Opus Genetics, Inc.
IRD
$4.90
-$0.29-5.61%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 13.80% | -150.82% | -313.15% | -418.72% | -476.13% |
| Total Depreciation and Amortization | 430.00% | 1,566.67% | 825.00% | 360.00% | 66.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -43.03% | 1,005.36% | 510.16% | 451.69% | 502.17% |
| Change in Net Operating Assets | -169.71% | -107.91% | 95.65% | -23.97% | -24.19% |
| Cash from Operations | -37.84% | -141.78% | -177.68% | -806.79% | -2,200.00% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 699.56% | 40.63% | -48.49% | -28.32% | -51.42% |
| Repurchase of Common Stock | -92.41% | -73.81% | -73.81% | -73.81% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 5,797.84% | 3,806.98% | 3,940.44% | 4,210.91% | 16.55% |
| Cash from Financing | 1,095.01% | 228.14% | 67.82% | 96.17% | -53.38% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 173.19% | -1.73% | -727.09% | -165.69% | -356.51% |